Remission of an Intracardiac Melanoma Metastasis after Tremelimumab Therapy
Tremelimumab is a fully human monoclonal antibody specific for human cytotoxic T lymphocyte-associated antigen 4. Administration of tremelimumab to patients with locally advanced and metastatic melanoma has resulted in a subset of patients with durable objective tumour regressions. Our echocardiogra...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
S. Karger AG
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975197/ |